VYXEOS® Efficacy - Phase 3 Trial Data vs 7+3 | VYXEOS® (daunorubicin and cytarabine)
Overall survival curve. Median overall survival time was 8.2 months.... | Download Scientific Diagram
Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters | PLOS ONE
View Image
Disparities in Care and Outcomes
Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis | SpringerLink
View Image
PADCEV® (enfortumab vedotin-ejfv) Efficacy in Patients with la/mUC
NEJM on Twitter: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months
Metastasectomy and Targeted Therapy for Patients With Spinal Metastases of Renal Cell Carcinoma | International Journal of Spine Surgery
View Image
IMFINZI® (durvalumab) Efficacy & Clinical Trials for ES-SCLC
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Median overall survival (mOS) and median progression-free survival... | Download Scientific Diagram
Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with (“pseudo-randomized”) treatment allocation by the health insurance provider | SpringerLink
Cureus | Impact of CyberKnife Radiosurgery on Median Overall Survival of Various Parameters in Patients with 1-12 Brain Metastases
Quality improvement program in radiation oncology: understanding patient hospitalizations, treatment breaks, and weight loss in patients receiving radiotherapy | Radiation Oncology | Full Text
survival - Time to event analysis - median (IQR) is <75% experience event - Cross Validated
Survival curves. (A) Overall survival (median 18.2 months). (B) PS of... | Download Scientific Diagram
Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery | Anticancer Research
VENCLEXTA® (venetoclax tablets) | VIALE-A Trial Overall Survival Data
Early Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced Pancreatic Cancer with
Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram
Cureus | Impact of CyberKnife Radiosurgery on Median Overall Survival of Various Parameters in Patients with 1-12 Brain Metastases
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
